Title: 
Official Title: To amend the Public Health Service Act to provide for the disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs, and for other purposes.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Safe Prescribing Through Reporting Act of 2025.

Section 2:
2.Disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programsSection 543(b)(2) of the Public Health Service Act (42 U.S.C. 290dd–2(b)(2)) is amended by adding at the end the following:

(E)To the applicable prescription drug monitoring program of a State if— (i)such record relates to the prescribing or dispensing of a substance use disorder medication; and
(ii)such disclosure is required by applicable State law..


================================================================================

Raw Text:
119 HR 3595 IH: Safe Prescribing Through Reporting Act of 2025
U.S. House of Representatives
2025-05-23
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 3595IN THE HOUSE OF REPRESENTATIVESMay 23, 2025Mr. Kennedy of Utah introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Public Health Service Act to provide for the disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs, and for other purposes. 
1.Short titleThis Act may be cited as the Safe Prescribing Through Reporting Act of 2025. 2.Disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programsSection 543(b)(2) of the Public Health Service Act (42 U.S.C. 290dd–2(b)(2)) is amended by adding at the end the following:

(E)To the applicable prescription drug monitoring program of a State if— (i)such record relates to the prescribing or dispensing of a substance use disorder medication; and
(ii)such disclosure is required by applicable State law..